Skip to main content
    L

    LENSAR Inc (LNSR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $5.29
    +0.29 (+5.80%)

    Market Cap: $61.47M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    LENSAR Inc (LNSR) Financials: Revenue, Profit and Cash Flow

    Updated Nov 10, 2026. Financial statements from company filings, amounts in US dollars.

    LENSAR reported revenue of $58.44M for the fiscal year ended Dec 31, 2025, up 9.2% from the year before. That year, net income was -$34.28M with a net margin of -58.7%, operating cash flow was -$14.83M and free cash flow was -$14.91M. The quarter ended Sep 30, 2026 had revenue of $14.13M and net income of -$4.72M.

    Revenue and Margins

    The operating margin was -42.1% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from $24.39M, a compound annual rate of 13.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$58.44M+9.2%46.4%-42.1%-58.7%
    Dec 2024$53.49M+26.9%48.3%-19.9%-58.7%
    Dec 2023$42.16M+19.2%50.1%-29.0%-34.1%
    Dec 2022$35.36M+2.6%56.4%-57.1%-56.3%
    Dec 2021$34.46M+30.6%51.8%-57.0%-56.9%
    Dec 2020$26.38M-13.6%53.4%-70.1%-75.0%
    Dec 2019$30.53M+25.2%43.3%-41.6%-48.0%
    Dec 2018$24.39MN/A39.4%-38.2%-51.6%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$58.44M$53.49M$42.16M$35.36M$34.46M$26.38M$30.53M$24.39M
    Cost of revenue$31.31M$27.64M$21.06M$15.40M$16.63M$12.31M$17.30M$14.78M
    Gross profit$27.12M$25.85M$21.11M$19.95M$17.83M$14.07M$13.23M$9.61M
    Research and development$5.62M$5.33M$6.14M$11.81M$12.36M$7.55M$7.57M$2.78M
    Operating income-$24.58M-$10.66M-$12.23M-$20.18M-$19.65M-$18.50M-$12.71M-$9.32M
    Net income-$34.28M-$31.40M-$14.38M-$19.91M-$19.60M-$19.77M-$14.66M-$12.59M
    EBITDAN/AN/A-$11.58M-$16.77M-$16.84M-$15.43M-$8.85M-$4.66M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$14.13M$16.50M$13.43M$16.02M$14.32M$13.94M$14.16M$16.73M$13.54M$12.64M$10.59M$12.11M
    Gross profit$8.16M$9.78M$6.38M$6.94M$6.04M$7.02M$7.13M$7.11M$6.27M$6.81M$5.66M$5.15M
    Operating income-$1.43M$2.13M$2.24M-$4.92M-$7.58M-$6.29M-$5.79M-$1.29M-$1.25M-$5.28M-$2.85M-$2.96M
    Net income-$4.72M$3.54M$36.33M-$1.46M-$3.71M-$1.76M-$27.34M-$18.70M-$1.50M-$9.04M-$2.16M-$3.93M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $747.00K by $12.23M. Shareholder equity was negative, at -$26.02M, as total liabilities of $83.67M exceeded total assets of $71.43M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$71.43M$66.30M$69.58M$55.84M$66.47M$79.12M$34.54M$28.89M
    Current assets$46.77M$41.98M$46.44M$33.72M$44.81M$58.38M$17.18M$11.75M
    Cash and equivalents$12.97M$16.26M$20.62M$14.67M$31.64M$40.60M$4.62M$3.34M
    Total liabilities$83.67M$47.65M$22.41M$13.86M$11.59M$11.91M$65.09M$49.35M
    Short-term debt$747.00K$524.00K$559.00K$531.00K$512.00K$493.00K$1.11M$653.00K
    Long-term debt$0N/AN/AN/AN/AN/A$20.20MN/A
    Shareholder equity-$26.02M$4.86M$33.43M$41.98M$54.88M$67.21M-$30.55M-$20.46M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$67.07M$69.56M$66.22M$71.43M$70.20M$70.41M$72.96M$66.30M$62.02M$61.41M$66.13M$69.58M
    Total liabilities$42.22M$40.87M$41.65M$97.45M$82.33M$79.68M$81.32M$61.44M$25.50M$23.98M$20.55M$36.16M
    Cash and equivalents$12.62M$13.56M$12.49M$12.97M$7.64M$7.15M$19.55M$16.26M$10.44M$8.29M$13.96M$20.62M
    Shareholder equity$11.07M$14.90M$10.79M-$26.02M-$25.91M-$23.05M-$22.14M$4.86M$22.74M$23.64M$31.84M$33.43M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-$14.83M-$2.27M-$9.66M-$14.86M-$8.97M-$13.79M-$12.59M-$1.89M
    Capital expenditures$83.00K$156.00K$236.00K$115.00K$354.00K$366.00K$389.00K$3.25M
    Free cash flow-$14.91M-$2.43M-$9.89M-$14.97M-$9.32M-$14.16M-$12.98M-$5.13M
    Dividends paidN/AN/AN/AN/A$0$1.86M$31.00K$198.00K
    Investing cash flow$1.28M-$2.16M-$4.16M-$115.00K-$354.00K-$326.00K-$2.09M-$3.89M
    Financing cash flow$10.26M$78.00K$19.76M-$1.99M$361.00K$50.00M$15.95M$6.96M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$866.00K-$127.00K-$4.27M$618.00K-$3.51M-$5.00M-$6.94M$3.66M$3.15M-$3.78M-$5.31M-$480.00K
    Capital expenditures$112.00K$35.00K$0$0$0$77.00K$6.00K$3.00K$20.00K$113.00K$20.00K$45.00K
    Free cash flow-$978.00K-$162.00K-$4.27M$618.00K-$3.51M-$5.08M-$6.94M$3.65M$3.13M-$3.89M-$5.33M-$525.00K
    Last 12 quarters

    Frequently Asked Questions About LNSR

    What is LENSAR's annual revenue?

    LENSAR reported revenue of $58.44M for the fiscal year ended Dec 31, 2025.

    How fast is LENSAR's revenue growing?

    Revenue was up 9.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 18.2%.

    Is LENSAR profitable?

    No. LENSAR reported net income of -$34.28M for the fiscal year ended Dec 31, 2025, with a net margin of -58.7%.

    How much free cash flow does LNSR generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$14.83M minus capital expenditures of $83.00K produced free cash flow of -$14.91M.

    How much debt does LENSAR have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $0, short-term debt of $747.00K and cash and equivalents of $12.97M.